Free Trial

Acacia Research (ACTG) Financials

Acacia Research logo
$2.89 -0.05 (-1.70%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$3.02 +0.13 (+4.64%)
As of 04/17/2025 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Acacia Research

Annual Income Statements for Acacia Research

This table shows Acacia Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-125 67 -36
Consolidated Net Income / (Loss)
-111 69 -35
Net Income / (Loss) Continuing Operations
-111 69 -35
Total Pre-Tax Income
-127 67 -38
Total Operating Income
-40 21 -33
Total Gross Profit
35 72 30
Total Revenue
72 125 122
Operating Revenue
59 125 122
Total Cost of Revenue
37 53 93
Operating Cost of Revenue
37 53 93
Total Operating Expenses
62 51 63
Selling, General & Admin Expense
53 44 55
Marketing Expense
8.62 6.91 7.22
Research & Development Expense
0.63 0.00 0.00
Total Other Income / (Expense), net
-100 46 -5.22
Interest Expense
6.43 2.06 6.44
Other Income / (Expense), net
-94 49 1.22
Income Tax Expense
-16 -1.50 -3.45
Net Income / (Loss) Attributable to Noncontrolling Interest
14 1.87 1.36
Basic Earnings per Share
($3.13) $0.73 ($0.36)
Weighted Average Basic Shares Outstanding
42.46M 75.30M 99.21M
Diluted Earnings per Share
($3.13) $0.58 ($0.36)
Weighted Average Diluted Shares Outstanding
58.57M 99.90M 96.09M
Weighted Average Basic & Diluted Shares Outstanding
58.57M 99.90M 96.09M

Quarterly Income Statements for Acacia Research

This table shows Acacia Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
28 59 15 -19 1.64 69 -0.37 -8.45 -14 -13
Consolidated Net Income / (Loss)
28 -19 9.45 -19 2.76 76 -0.19 -8.83 -12 -14
Net Income / (Loss) Continuing Operations
28 -19 9.45 -19 2.76 76 -0.19 -8.83 -12 -14
Total Pre-Tax Income
29 -20 12 -20 2.57 73 -1.30 -16 -6.16 -15
Total Operating Income
-11 -15 -9.32 -13 -13 56 -2.09 -4.76 -10 -16
Total Gross Profit
48 19 4.85 -11 1.76 77 12 6.76 2.35 8.59
Total Revenue
58 20 15 -2.03 12 101 24 26 23 49
Operating Revenue
16 13 15 7.90 10 92 24 26 23 49
Total Cost of Revenue
9.93 0.72 9.96 8.94 9.85 24 12 19 21 40
Operating Cost of Revenue
9.93 0.72 9.96 8.94 9.85 24 12 19 21 40
Total Operating Expenses
17 18 14 11 13 12 14 12 13 24
Selling, General & Admin Expense
15 16 12 9.43 12 11 12 9.95 11 22
Marketing Expense
2.12 2.19 1.91 1.86 1.61 1.52 1.56 1.39 1.39 2.88
Research & Development Expense
0.16 0.14 0.22 0.21 0.17 -0.59 0.13 0.18 0.11 -0.42
Total Other Income / (Expense), net
-1.20 -12 21 2.04 14 9.00 0.79 -11 4.11 1.01
Interest Expense
1.07 -171 0.90 0.90 0.13 0.13 0.00 0.00 0.00 6.44
Other Income / (Expense), net
-0.13 -183 24 2.94 14 7.78 -28 -11 4.11 36
Income Tax Expense
0.68 -1.81 2.48 -1.65 -0.20 -2.15 -1.11 -7.06 5.50 -0.78
Net Income / (Loss) Attributable to Noncontrolling Interest
0.31 -0.19 -9.45 0.00 1.13 10 0.19 -0.38 2.34 -0.78
Basic Earnings per Share
$0.54 ($0.62) $0.12 ($0.36) ($0.02) $0.99 $0.00 ($0.08) ($0.14) ($0.14)
Weighted Average Basic Shares Outstanding
38.05M 42.46M 47.97M 58.41M 94.33M 75.30M 99.75M 100.08M 99.85M 99.21M
Diluted Earnings per Share
$0.02 ($0.10) ($0.07) ($0.36) ($0.03) $1.04 $0.00 ($0.08) ($0.14) ($0.14)
Weighted Average Diluted Shares Outstanding
43.54M 58.57M 89.07M 299.66M 99.89M 99.90M 99.75M 100.38M 97.37M 96.09M
Weighted Average Basic & Diluted Shares Outstanding
43.54M 58.57M 58.55M 299.66M 99.89M 99.90M 100.02M 100.38M 97.37M 96.09M

Annual Cash Flow Statements for Acacia Research

This table details how cash moves in and out of Acacia Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents
-22 52 -65
Net Cash From Operating Activities
-37 -23 50
Net Cash From Continuing Operating Activities
-37 -23 50
Net Income / (Loss) Continuing Operations
-111 69 -35
Consolidated Net Income / (Loss)
-111 69 -35
Depreciation Expense
14 15 34
Non-Cash Adjustments To Reconcile Net Income
90 -30 3.97
Changes in Operating Assets and Liabilities, net
-30 -76 47
Net Cash From Investing Activities
184 16 -213
Net Cash From Continuing Investing Activities
184 16 -213
Purchase of Property, Plant & Equipment
-0.73 -0.19 -149
Acquisitions
-5.00 -15 -102
Purchase of Investments
-112 -13 -20
Sale and/or Maturity of Investments
302 35 58
Other Investing Activities, net
- 9.97 0.00
Net Cash From Financing Activities
-166 59 98
Net Cash From Continuing Financing Activities
-166 59 98
Repayment of Debt
-120 -68 -30
Repurchase of Common Equity
-51 0.00 -20
Payment of Dividends
-2.80 -1.40 0.00
Issuance of Debt
- 0.00 133
Issuance of Common Equity
- 0.00 15
Other Financing Activities, net
7.65 128 -0.87
Cash Interest Paid
7.23 2.51 5.06
Cash Income Taxes Paid
0.38 0.83 1.05

Quarterly Cash Flow Statements for Acacia Research

This table details how cash moves in and out of Acacia Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-22 46 76 -9.04 -10 -4.64 99 -52 -27 -85
Net Cash From Operating Activities
3.96 -24 -4.35 -15 1.16 -4.54 55 16 -0.57 -20
Net Cash From Continuing Operating Activities
3.96 -24 -4.35 -15 1.16 -4.54 55 16 -0.94 -20
Net Income / (Loss) Continuing Operations
28 -19 9.45 -19 2.76 76 -0.19 -8.83 -12 -14
Consolidated Net Income / (Loss)
28 -19 9.45 -19 2.76 76 -0.19 -8.83 -12 -14
Depreciation Expense
3.36 3.37 3.38 3.41 3.36 4.58 4.57 7.41 9.76 12
Non-Cash Adjustments To Reconcile Net Income
-35 5.27 -18 12 -12 -12 -8.47 10 -1.16 3.23
Changes in Operating Assets and Liabilities, net
7.36 -14 0.70 -11 7.00 -73 59 6.92 2.11 -21
Net Cash From Investing Activities
46 60 2.78 6.44 -0.60 7.56 42 -152 -7.23 -96
Net Cash From Continuing Investing Activities
46 60 2.78 6.44 -0.60 7.56 42 -152 -7.23 -96
Purchase of Property, Plant & Equipment
-0.14 -0.18 -0.08 -0.05 -0.02 -0.04 -0.27 -143 -2.23 -3.29
Acquisitions
- - - - - -15 - - -5.00 -88
Purchase of Investments
- -4.61 -5.17 -0.68 -2.84 -4.39 -16 - - -4.93
Net Cash From Financing Activities
-68 8.47 78 -0.67 -11 -7.72 1.83 84 -19 31
Net Cash From Continuing Financing Activities
-68 8.47 78 -0.67 -11 -7.72 1.83 84 -19 31
Repayment of Debt
-55 - - - - -7.70 - - - -18
Repurchase of Common Equity
-11 - - - - - - - - -13
Issuance of Debt
- - 0.00 - - - 2.50 69 - 62
Other Financing Activities, net
-1.02 9.17 79 0.03 49 -0.02 -0.67 -0.17 - -0.02
Cash Interest Paid
0.55 1.80 0.00 1.80 0.58 0.13 0.32 0.13 2.26 2.35
Cash Income Taxes Paid
0.17 0.18 0.15 0.40 0.17 0.11 0.12 0.27 0.08 0.59

Annual Balance Sheets for Acacia Research

This table presents Acacia Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Total Assets
483 634 756
Total Current Assets
428 555 420
Cash & Equivalents
288 340 274
Short-Term Investments
98 100 60
Accounts Receivable
8.23 81 27
Inventories, net
14 11 27
Prepaid Expenses
19 23 32
Plant, Property, & Equipment, net
3.54 2.36 24
Total Noncurrent Assets
51 77 312
Goodwill
7.54 8.99 29
Intangible Assets
37 34 55
Noncurrent Deferred & Refundable Income Taxes
0.00 2.92 20
Other Noncurrent Operating Assets
7.21 31 207
Total Liabilities & Shareholders' Equity
483 634 756
Total Liabilities
194 44 204
Total Current Liabilities
87 28 47
Accounts Payable
20 12 33
Current Deferred Revenue
1.23 0.98 1.32
Current Employee Benefit Liabilities
4.74 4.21 6.28
Other Current Liabilities
0.70 11 6.99
Total Noncurrent Liabilities
106 16 157
Long-Term Debt
0.00 11 114
Asset Retirement Reserve & Litigation Obligation
- 0.29 31
Noncurrent Deferred & Payable Income Tax Liabilities
0.74 0.00 2.61
Other Noncurrent Operating Liabilities
105 5.48 8.87
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
269 590 553
Total Preferred & Common Equity
258 568 515
Preferred Stock
0.00 0.00 0.00
Total Common Equity
258 568 515
Common Stock
663 906 910
Retained Earnings
-307 -240 -276
Treasury Stock
-98 -98 -119
Accumulated Other Comprehensive Income / (Loss)
- 0.00 -1.18
Noncontrolling Interest
11 21 38

Quarterly Balance Sheets for Acacia Research

This table presents Acacia Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
485 557 535 529 632 754 708
Total Current Assets
427 505 486 484 553 494 458
Cash & Equivalents
242 364 355 345 439 387 360
Short-Term Investments
159 97 90 101 60 55 51
Accounts Receivable
7.04 8.67 6.27 5.90 15 19 11
Inventories, net
14 15 14 12 9.88 12 12
Prepaid Expenses
5.17 20 21 20 29 21 24
Plant, Property, & Equipment, net
3.70 3.28 2.95 2.65 2.09 2.32 2.37
Total Noncurrent Assets
54 48 46 42 76 257 248
Goodwill
7.47 7.54 7.54 7.54 8.99 8.99 8.99
Intangible Assets
40 34 31 28 30 36 31
Noncurrent Deferred & Refundable Income Taxes
- - - 0.32 6.57 14 8.42
Other Noncurrent Operating Assets
7.21 6.97 7.84 6.63 31 198 199
Total Liabilities & Shareholders' Equity
485 557 535 529 632 754 708
Total Liabilities
184 179 176 26 42 157 129
Total Current Liabilities
85 90 78 21 26 44 28
Accounts Payable
14 21 10 14 8.69 18 14
Current Deferred Revenue
1.40 1.21 1.02 1.15 1.07 0.91 1.27
Current Employee Benefit Liabilities
5.07 5.49 5.51 5.20 4.62 3.98 4.97
Other Current Liabilities
3.26 1.06 0.58 1.30 3.01 6.41 7.76
Total Noncurrent Liabilities
99 89 98 4.12 16 113 101
Long-Term Debt
- - - - 13 82 70
Asset Retirement Reserve & Litigation Obligation
- - - - - 28 28
Other Noncurrent Operating Liabilities
95 88 98 3.62 2.89 2.93 3.02
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
282 356 335 504 590 597 579
Total Preferred & Common Equity
258 345 324 493 568 561 540
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
258 345 324 493 568 561 540
Common Stock
644 740 739 905 906 907 908
Retained Earnings
-288 -297 -316 -314 -240 -248 -262
Treasury Stock
-98 -98 -98 -98 -98 -98 -106
Noncontrolling Interest
25 11 11 11 21 36 38

Annual Metrics and Ratios for Acacia Research

This table displays calculated financial ratios and metrics derived from Acacia Research's official financial filings.

Metric 2022 2023 2024
Growth Metrics
- - -
Revenue Growth
51.82% 72.97% -2.23%
EBITDA Growth
-152.22% 170.05% -97.78%
EBIT Growth
-161.00% 151.93% -145.63%
NOPAT Growth
-324.11% 176.26% -207.69%
Net Income Growth
-173.78% 162.13% -150.34%
EPS Growth
-263.87% 118.53% -162.07%
Operating Cash Flow Growth
-380.17% 39.72% 322.71%
Free Cash Flow Firm Growth
-384.48% -187.79% -6.18%
Invested Capital Growth
44.18% 452.55% 107.73%
Revenue Q/Q Growth
-4.14% 183.60% -32.95%
EBITDA Q/Q Growth
-128.18% 147.31% -93.66%
EBIT Q/Q Growth
-132.42% 136.28% -1,111.74%
NOPAT Q/Q Growth
-628.25% 161.70% -154.15%
Net Income Q/Q Growth
-198.92% 374.09% -163.29%
EPS Q/Q Growth
-621.67% 203.57% -143.90%
Operating Cash Flow Q/Q Growth
-514.57% 46.03% -23.87%
Free Cash Flow Firm Q/Q Growth
70.36% -40.49% -42.31%
Invested Capital Q/Q Growth
-16.93% 178.15% 40.05%
Profitability Metrics
- - -
Gross Margin
48.31% 57.77% 24.24%
EBITDA Margin
-166.22% 67.32% 1.53%
Operating Margin
-55.43% 16.74% -26.92%
EBIT Margin
-185.03% 55.55% -25.92%
Profit (Net Income) Margin
-153.39% 55.10% -28.37%
Tax Burden Percent
87.25% 102.23% 90.96%
Interest Burden Percent
95.02% 97.03% 120.31%
Effective Tax Rate
0.00% -2.23% 0.00%
Return on Invested Capital (ROIC)
0.00% 37.29% -9.35%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 24.85% -5.76%
Return on Net Nonoperating Assets (RNNOA)
0.00% -21.61% 3.27%
Return on Equity (ROE)
-30.21% 15.69% -6.08%
Cash Return on Invested Capital (CROIC)
0.00% -115.01% -79.37%
Operating Return on Assets (OROA)
-20.88% 12.45% -4.56%
Return on Assets (ROA)
-17.31% 12.35% -4.99%
Return on Common Equity (ROCE)
-27.87% 14.75% -5.76%
Return on Equity Simple (ROE_SIMPLE)
-42.95% 12.13% -6.74%
Net Operating Profit after Tax (NOPAT)
-28 21 -23
NOPAT Margin
-38.80% 17.11% -18.84%
Net Nonoperating Expense Percent (NNEP)
-19.24% 12.44% -3.59%
Return On Investment Capital (ROIC_SIMPLE)
- 3.57% -3.46%
Cost of Revenue to Revenue
51.69% 42.23% 75.76%
SG&A Expenses to Revenue
72.84% 35.51% 45.26%
R&D to Revenue
0.87% 0.00% 0.00%
Operating Expenses to Revenue
85.62% 41.04% 51.16%
Earnings before Interest and Taxes (EBIT)
-134 69 -32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-120 84 1.87
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.71 0.69 0.82
Price to Tangible Book Value (P/TBV)
0.86 0.74 0.98
Price to Revenue (P/Rev)
2.53 3.13 3.45
Price to Earnings (P/E)
0.00 5.84 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 17.13% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.72
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 1.97
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 128.94
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 4.80
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.21 0.02 0.21
Long-Term Debt to Equity
0.00 0.02 0.21
Financial Leverage
-1.17 -0.87 -0.57
Leverage Ratio
1.75 1.27 1.22
Compound Leverage Factor
1.66 1.23 1.46
Debt to Total Capital
17.29% 1.75% 17.10%
Short-Term Debt to Total Capital
17.29% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 1.75% 17.10%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
8.86% 3.56% 5.67%
Common Equity to Total Capital
73.86% 94.69% 77.23%
Debt to EBITDA
-0.50 0.13 61.09
Net Debt to EBITDA
2.71 -5.10 -117.78
Long-Term Debt to EBITDA
0.00 0.13 61.09
Debt to NOPAT
-2.15 0.49 -4.95
Net Debt to NOPAT
11.61 -20.06 9.54
Long-Term Debt to NOPAT
0.00 0.49 -4.95
Altman Z-Score
-0.24 6.37 1.35
Noncontrolling Interest Sharing Ratio
7.73% 5.95% 5.18%
Liquidity Ratios
- - -
Current Ratio
4.91 20.06 8.89
Quick Ratio
4.52 18.83 7.64
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-64 -184 -196
Operating Cash Flow to CapEx
-5,100.55% -11,907.94% 33.71%
Free Cash Flow to Firm to Interest Expense
-9.95 -89.32 -30.39
Operating Cash Flow to Interest Expense
-5.80 -10.91 7.78
Operating Cash Flow Less CapEx to Interest Expense
-5.92 -11.00 -15.30
Efficiency Ratios
- - -
Asset Turnover
0.11 0.22 0.18
Accounts Receivable Turnover
8.15 2.82 2.28
Inventory Turnover
3.23 4.20 4.83
Fixed Asset Turnover
18.74 42.46 9.33
Accounts Payable Turnover
2.35 3.33 4.18
Days Sales Outstanding (DSO)
44.78 129.52 160.35
Days Inventory Outstanding (DIO)
113.01 86.86 75.64
Days Payable Outstanding (DPO)
155.03 109.72 87.28
Cash Conversion Cycle (CCC)
2.76 106.66 148.71
Capital & Investment Metrics
- - -
Invested Capital
-45 160 333
Invested Capital Turnover
-1.14 2.18 0.50
Increase / (Decrease) in Invested Capital
36 206 173
Enterprise Value (EV)
-111 -16 241
Market Capitalization
183 392 423
Book Value per Share
$6.08 $5.69 $5.29
Tangible Book Value per Share
$5.04 $5.26 $4.42
Total Capital
350 600 667
Total Debt
60 11 114
Total Long-Term Debt
0.00 11 114
Net Debt
-326 -429 -220
Capital Expenditures (CapEx)
0.73 0.19 149
Debt-free, Cash-free Net Working Capital (DFCFNWC)
15 87 39
Debt-free Net Working Capital (DFNWC)
401 527 373
Net Working Capital (NWC)
341 527 373
Net Nonoperating Expense (NNE)
83 -48 12
Net Nonoperating Obligations (NNO)
-335 -429 -220
Total Depreciation and Amortization (D&A)
14 15 34
Debt-free, Cash-free Net Working Capital to Revenue
20.85% 69.52% 32.00%
Debt-free Net Working Capital to Revenue
554.75% 421.16% 304.88%
Net Working Capital to Revenue
471.17% 421.16% 304.88%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($3.13) $0.73 ($0.36)
Adjusted Weighted Average Basic Shares Outstanding
42.46M 75.30M 99.21M
Adjusted Diluted Earnings per Share
($3.13) $0.58 ($0.36)
Adjusted Weighted Average Diluted Shares Outstanding
58.57M 99.90M 96.09M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
58.57M 99.90M 96.09M
Normalized Net Operating Profit after Tax (NOPAT)
-28 15 -23
Normalized NOPAT Margin
-38.80% 11.71% -18.84%
Pre Tax Income Margin
-175.80% 53.90% -31.19%
Debt Service Ratios
- - -
EBIT to Interest Expense
-20.81 33.68 -4.92
NOPAT to Interest Expense
-4.36 10.37 -3.58
EBIT Less CapEx to Interest Expense
-20.92 33.59 -28.01
NOPAT Less CapEx to Interest Expense
-4.48 10.28 -26.67
Payout Ratios
- - -
Dividend Payout Ratio
-2.52% 2.03% 0.00%
Augmented Payout Ratio
-48.48% 2.03% -58.47%

Quarterly Metrics and Ratios for Acacia Research

This table displays calculated financial ratios and metrics derived from Acacia Research's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
3,535.65% -13.67% 9.60% 88.98% -79.82% 410.47% 64.29% 1,372.18% 100.79% -51.51%
EBITDA Growth
-128.50% -154.96% -80.27% 15.00% 156.00% 135.22% -245.64% -37.28% -20.54% -52.65%
EBIT Growth
-144.94% -156.49% -83.43% 10.26% 110.18% 132.30% -312.52% -65.71% -626.50% -67.82%
NOPAT Growth
12.74% -136.32% -23.97% -120.97% -27.60% 665.36% 80.21% 62.02% 49.23% -119.22%
Net Income Growth
-68.36% -109.08% 112.89% 60.46% -90.27% 506.37% -102.00% 52.98% -522.05% -118.57%
EPS Growth
-97.67% -102.75% 95.65% 75.00% -250.00% 1,140.00% 100.00% 77.78% -366.67% -113.46%
Operating Cash Flow Growth
416.15% -205.02% -37.50% -2.66% -70.67% 80.86% 1,360.96% 209.09% -149.22% -345.91%
Free Cash Flow Firm Growth
-166.25% -221.36% 90.49% 73.92% 52.40% -220.90% -549.44% -421.46% -69.25% -24.03%
Invested Capital Growth
85.06% 44.18% 31.43% 62.11% 248.21% 452.55% 457.02% 1,019.60% 312.59% 107.73%
Revenue Q/Q Growth
412.10% -65.69% -24.98% -113.72% 671.59% 767.61% -77.68% 6.24% -9.78% 109.54%
EBITDA Q/Q Growth
-11.30% -2,295.89% 109.06% -135.18% 173.34% 1,406.57% -142.71% 66.84% 142.45% 797.83%
EBIT Q/Q Growth
-7.54% -1,616.97% 107.19% -167.57% 112.20% 5,345.90% -154.49% 47.31% 61.23% 432.81%
NOPAT Q/Q Growth
-179.66% 8.25% 27.50% -18.78% -61.49% 506.53% -102.44% -127.98% -115.89% -53.90%
Net Income Q/Q Growth
159.79% -165.43% 150.85% -298.78% 114.71% 2,633.53% -100.25% -4,571.43% -32.03% -20.30%
EPS Q/Q Growth
101.39% -600.00% 30.00% -414.29% 91.67% 3,566.67% -100.00% 0.00% -75.00% 0.00%
Operating Cash Flow Q/Q Growth
127.48% -700.20% 81.68% -239.69% 107.85% -491.72% 1,306.84% -70.61% -103.54% -3,448.51%
Free Cash Flow Firm Q/Q Growth
-18.85% 80.15% 55.01% -145.60% -116.95% -33.86% 7.49% -97.20% 29.58% 1.91%
Invested Capital Q/Q Growth
42.83% -16.93% 35.78% 11.76% 323.67% 178.15% -34.97% 127.29% 0.35% 40.05%
Profitability Metrics
- - - - - - - - - -
Gross Margin
82.74% 96.35% 32.73% 0.00% 15.18% 76.09% 49.16% 26.16% 10.09% 17.59%
EBITDA Margin
-14.07% -982.83% 118.71% 0.00% 39.05% 67.80% -105.23% -32.84% 15.45% 66.21%
Operating Margin
-19.76% -73.74% -62.99% 0.00% -113.30% 55.54% -8.58% -18.41% -44.07% -32.37%
EBIT Margin
-19.98% -999.93% 95.87% 0.00% 10.08% 63.26% -124.01% -61.50% -26.43% 41.97%
Profit (Net Income) Margin
49.37% -94.16% 63.82% 0.00% 23.79% 74.96% -0.78% -34.17% -50.01% -28.71%
Tax Burden Percent
97.66% 91.11% 79.19% 91.95% 107.68% 102.92% 14.56% 55.56% 189.24% 94.76%
Interest Burden Percent
-253.02% 10.34% 84.07% 212.99% 219.23% 115.13% 4.30% 100.00% 100.00% -72.19%
Effective Tax Rate
2.34% 0.00% 20.81% 0.00% -7.68% -2.92% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% -574.45% 124.62% -22.88% -20.85% -38.12% -11.24%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% -578.76% 119.93% -23.17% -19.37% -36.98% -10.33%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 565.28% -104.26% 21.37% 15.09% 26.89% 5.87%
Return on Equity (ROE)
41.78% -30.21% -7.64% 0.15% -9.17% 20.35% -1.51% -5.76% -11.23% -5.37%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% -227.69% -115.01% -98.43% -92.98% -93.13% -79.37%
Operating Return on Assets (OROA)
-2.44% -112.84% 11.59% 0.00% 0.88% 14.18% -29.82% -16.30% -7.80% 7.39%
Return on Assets (ROA)
6.03% -10.63% 7.71% 0.00% 2.07% 16.80% -0.19% -9.06% -14.75% -5.05%
Return on Common Equity (ROCE)
37.49% -27.87% -7.03% 0.13% -8.55% 19.14% -1.43% -5.34% -10.71% -5.09%
Return on Equity Simple (ROE_SIMPLE)
43.52% 0.00% -8.19% 0.15% -5.11% 0.00% 10.43% 12.35% 10.15% 0.00%
Net Operating Profit after Tax (NOPAT)
-11 -10 -7.38 -8.77 -14 58 -1.46 -3.33 -7.19 -11
NOPAT Margin
-19.30% -51.62% -49.88% 0.00% -122.00% 57.17% -6.01% -12.89% -30.85% -22.66%
Net Nonoperating Expense Percent (NNEP)
9.45% -1.95% 4.15% -2.71% 4.31% 4.69% 0.29% -1.48% -1.14% -0.91%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - 9.59% - - - -1.66%
Cost of Revenue to Revenue
17.26% 3.65% 67.27% 0.00% 84.82% 23.91% 50.84% 73.84% 89.91% 82.41%
SG&A Expenses to Revenue
26.15% 80.42% 81.33% 0.00% 99.97% 11.28% 50.79% 38.51% 47.72% 44.91%
R&D to Revenue
0.27% 0.68% 1.46% 0.00% 1.48% -0.59% 0.55% 0.69% 0.46% -0.86%
Operating Expenses to Revenue
30.10% 92.21% 95.72% 0.00% 115.34% 12.20% 57.74% 44.57% 54.15% 49.95%
Earnings before Interest and Taxes (EBIT)
-11 -197 14 -9.59 1.17 64 -30 -16 -6.16 21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-8.09 -194 18 -6.18 4.53 68 -26 -8.49 3.60 32
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.60 0.71 0.66 0.75 0.74 0.69 0.94 0.89 0.87 0.82
Price to Tangible Book Value (P/TBV)
0.74 0.86 0.74 0.85 0.80 0.74 1.01 0.97 0.93 0.98
Price to Revenue (P/Rev)
2.05 2.53 3.07 2.71 8.27 3.13 3.73 2.94 2.56 3.45
Price to Earnings (P/E)
0.00 0.00 5.57 2.92 6.41 5.84 10.38 8.13 10.17 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 17.95% 34.20% 15.59% 17.13% 9.63% 12.30% 9.83% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.66 0.75 0.70 0.72
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.48 1.04 0.91 1.97
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 2.09 5.84 5.61 128.94
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 4.08 16.94 52.72 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 2.22 4.18 3.88 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 1.86 2.62 2.51 4.80
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.20 0.21 0.16 0.17 0.00 0.02 0.02 0.14 0.12 0.21
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.14 0.12 0.21
Financial Leverage
-1.56 -1.17 -1.10 -1.15 -0.98 -0.87 -0.92 -0.78 -0.73 -0.57
Leverage Ratio
2.30 1.75 1.65 1.70 1.26 1.27 1.23 1.35 1.14 1.22
Compound Leverage Factor
-5.82 0.18 1.39 3.63 2.76 1.46 0.05 1.35 1.14 -0.88
Debt to Total Capital
16.93% 17.29% 13.99% 14.43% 0.00% 1.75% 2.16% 12.08% 10.79% 17.10%
Short-Term Debt to Total Capital
16.93% 17.29% 13.99% 14.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 1.75% 2.16% 12.08% 10.79% 17.10%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
11.94% 8.86% 7.42% 8.16% 2.19% 3.56% 3.54% 5.31% 5.92% 5.67%
Common Equity to Total Capital
71.13% 73.86% 78.59% 77.41% 97.81% 94.69% 94.30% 82.61% 83.29% 77.23%
Debt to EBITDA
0.14 -0.50 -0.32 -0.32 0.00 0.13 0.40 2.70 2.38 61.09
Net Debt to EBITDA
-0.80 2.71 2.09 2.02 0.00 -5.10 -14.85 -11.85 -11.58 -117.78
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.13 0.40 2.70 2.38 61.09
Debt to NOPAT
11.55 -2.15 -2.14 -0.50 0.00 0.49 0.42 1.94 1.64 -4.95
Net Debt to NOPAT
-63.97 11.61 13.98 3.15 0.00 -20.06 -15.75 -8.49 -8.01 9.54
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.49 0.42 1.94 1.64 -4.95
Altman Z-Score
0.59 -0.67 1.12 1.03 8.87 6.34 8.12 2.33 2.61 1.58
Noncontrolling Interest Sharing Ratio
10.28% 7.73% 8.05% 11.86% 6.75% 5.95% 5.57% 7.35% 4.57% 5.18%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
5.00 4.91 5.60 6.24 22.60 20.06 21.40 11.17 16.39 8.89
Quick Ratio
4.78 4.52 5.21 5.80 21.08 18.83 19.88 10.42 15.10 7.64
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-232 -46 -21 -51 -111 -148 -135 -266 -187 -184
Operating Cash Flow to CapEx
2,785.21% -13,187.78% -5,239.76% -27,357.41% 7,733.33% -12,281.08% 20,310.74% 11.28% -25.56% -615.87%
Free Cash Flow to Firm to Interest Expense
-216.82 0.00 -23.07 -56.66 -851.03 -1,113.50 0.00 0.00 0.00 -28.53
Operating Cash Flow to Interest Expense
3.69 0.00 -4.83 -16.41 8.92 -34.17 0.00 0.00 0.00 -3.15
Operating Cash Flow Less CapEx to Interest Expense
3.56 0.00 -4.92 -16.47 8.81 -34.44 0.00 0.00 0.00 -3.66
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.12 0.11 0.12 0.16 0.09 0.22 0.24 0.27 0.30 0.18
Accounts Receivable Turnover
5.20 8.15 8.27 9.02 6.82 2.82 11.89 13.64 21.94 2.28
Inventory Turnover
0.00 3.23 2.41 2.27 2.25 4.20 4.49 4.97 6.22 4.83
Fixed Asset Turnover
0.00 18.74 20.56 26.35 13.90 42.46 53.26 64.85 72.78 9.33
Accounts Payable Turnover
4.90 2.35 1.77 2.62 2.09 3.33 3.71 4.56 5.52 4.18
Days Sales Outstanding (DSO)
70.13 44.78 44.14 40.46 53.52 129.52 30.71 26.77 16.64 160.35
Days Inventory Outstanding (DIO)
0.00 113.01 151.33 160.95 162.12 86.86 81.30 73.41 58.68 75.64
Days Payable Outstanding (DPO)
74.48 155.03 206.48 139.42 174.28 109.72 98.46 79.98 66.12 87.28
Cash Conversion Cycle (CCC)
-4.36 2.76 -11.00 62.00 41.36 106.66 13.55 20.20 9.19 148.71
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
-39 -45 -29 -26 58 160 104 237 238 333
Invested Capital Turnover
-0.50 -1.14 -2.05 -1.92 4.71 2.18 3.81 1.62 1.24 0.50
Increase / (Decrease) in Invested Capital
221 36 13 42 96 206 133 263 180 173
Enterprise Value (EV)
-142 -111 -142 -107 -70 -16 68 177 165 241
Market Capitalization
155 183 226 244 365 392 532 501 468 423
Book Value per Share
$6.73 $6.08 $5.88 $5.54 $4.93 $5.69 $5.69 $5.61 $5.38 $5.29
Tangible Book Value per Share
$5.50 $5.04 $5.18 $4.89 $4.58 $5.26 $5.30 $5.16 $4.98 $4.42
Total Capital
362 350 439 419 504 600 603 679 649 667
Total Debt
61 60 61 60 0.00 11 13 82 70 114
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 11 13 82 70 114
Net Debt
-340 -326 -400 -384 -446 -429 -485 -360 -341 -220
Capital Expenditures (CapEx)
0.14 0.18 0.08 0.05 0.02 0.04 0.27 143 2.23 3.29
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1.93 15 15 24 17 87 29 7.82 19 39
Debt-free Net Working Capital (DFNWC)
403 401 476 468 463 527 527 450 430 373
Net Working Capital (NWC)
342 341 415 408 463 527 527 450 430 373
Net Nonoperating Expense (NNE)
-39 8.39 -17 10 -17 -18 -1.27 5.50 4.47 2.96
Net Nonoperating Obligations (NNO)
-340 -335 -406 -384 -446 -429 -485 -360 -341 -220
Total Depreciation and Amortization (D&A)
3.40 3.37 3.38 3.41 3.36 4.58 4.57 7.41 9.76 12
Debt-free, Cash-free Net Working Capital to Revenue
2.56% 20.85% 19.87% 26.27% 38.58% 69.52% 20.21% 4.58% 10.32% 32.00%
Debt-free Net Working Capital to Revenue
534.29% 554.75% 647.00% 520.37% 1,049.63% 421.16% 369.10% 263.42% 235.56% 304.88%
Net Working Capital to Revenue
452.97% 471.17% 563.67% 453.22% 1,049.63% 421.16% 369.10% 263.42% 235.56% 304.88%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.54 ($0.62) $0.12 ($0.36) ($0.02) $0.99 $0.00 ($0.08) ($0.14) ($0.14)
Adjusted Weighted Average Basic Shares Outstanding
38.05M 42.46M 47.97M 58.41M 94.33M 75.30M 99.75M 100.08M 99.85M 99.21M
Adjusted Diluted Earnings per Share
$0.02 ($0.10) ($0.07) ($0.36) ($0.03) $1.04 $0.00 ($0.08) ($0.14) ($0.14)
Adjusted Weighted Average Diluted Shares Outstanding
43.54M 58.57M 89.07M 299.66M 99.89M 99.90M 99.75M 100.38M 97.37M 96.09M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
43.54M 58.57M 58.55M 299.66M 99.89M 99.90M 100.02M 100.38M 97.37M 96.09M
Normalized Net Operating Profit after Tax (NOPAT)
-11 -10 -7.38 -8.77 -9.21 39 -1.46 -3.33 -7.19 -11
Normalized NOPAT Margin
-19.30% -51.62% -49.88% 0.00% -79.31% 38.88% -6.01% -12.89% -30.85% -22.66%
Pre Tax Income Margin
50.55% -103.35% 80.59% 0.00% 22.09% 72.83% -5.34% -61.50% -26.43% -30.30%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-10.72 0.00 15.77 -10.65 9.00 479.08 0.00 0.00 0.00 3.18
NOPAT to Interest Expense
-10.35 0.00 -8.20 -9.74 -108.95 432.92 0.00 0.00 0.00 -1.72
EBIT Less CapEx to Interest Expense
-10.85 0.00 15.68 -10.71 8.88 478.80 0.00 0.00 0.00 2.67
NOPAT Less CapEx to Interest Expense
-10.49 0.00 -8.30 -9.80 -109.06 432.64 0.00 0.00 0.00 -2.23
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
2.47% -2.52% -9.92% 577.32% -8.35% 2.03% 1.18% 0.00% 0.00% 0.00%
Augmented Payout Ratio
51.51% -48.48% -9.92% 577.32% -8.35% 2.03% 1.18% 0.00% 13.32% -58.47%

Frequently Asked Questions About Acacia Research's Financials

When does Acacia Research's financial year end?

According to the most recent income statement we have on file, Acacia Research's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Acacia Research's net income changed over the last 2 years?

Acacia Research's net income appears to be on a downward trend, with a most recent value of -$34.70 million in 2024, falling from -$110.94 million in 2022. The previous period was $68.93 million in 2023.

What is Acacia Research's operating income?
Acacia Research's total operating income in 2024 was -$32.93 million, based on the following breakdown:
  • Total Gross Profit: $29.65 million
  • Total Operating Expenses: $62.58 million
How has Acacia Research revenue changed over the last 2 years?

Over the last 2 years, Acacia Research's total revenue changed from $72.33 million in 2022 to $122.31 million in 2024, a change of 69.1%.

How much debt does Acacia Research have?

Acacia Research's total liabilities were at $203.78 million at the end of 2024, a 363.8% increase from 2023, and a 5.2% increase since 2022.

How much cash does Acacia Research have?

In the past 2 years, Acacia Research's cash and equivalents has ranged from $273.88 million in 2024 to $340.09 million in 2023, and is currently $273.88 million as of their latest financial filing in 2024.

How has Acacia Research's book value per share changed over the last 2 years?

Over the last 2 years, Acacia Research's book value per share changed from 6.08 in 2022 to 5.29 in 2024, a change of -13.1%.



This page (NASDAQ:ACTG) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners